URALCHEM
and the fund of Ziedot.lv, have agreed to work together to help
seriously ill children who need specific treatment or rehabilitation
using leading Russian clinics.
Riga,
Latvia - October 3, 2012 – URALCHEM
and a leading charitable organization of Latvia, the fund of
Ziedot.lv,
have agreed to work together to help seriously ill children who need
specific treatment or rehabilitation using leading Russian clinics.
URALCHEM will provide funding for the hospitalization and treatment
of children to the amount of 80 thousand Euros. A corresponding
agreement has been signed today by URALCHEM CEO Dmitry Konyaev and
Manager of the Fund Ziedot.lv Ruta Dimanta.
Dmitry
Konyaev, CEO of URALCHEM, OJSC:
"Since
2009, URALCHEM has been implementing a large-scale logistics project
involving the creation of a terminal for transhipment of mineral
fertilizers in the Latvian port of Riga. Traditionally, in all
regions where URALCHEM does business, we pursue a socially
responsible policy, which aims to address the socio-economic problems
of the people of these regions. One of the priorities of our policy
has always been to help children. In a joint program with Ziedot.lv
we will help families of different nationalities living in Latvia who
need financial and medical assistance."
Ruta
Dimanta, Head of the Fund Ziedot.lv:
"The
programme will help seriously ill children who need treatment in
Russian clinics, and whose families are not able to cover all the
costs. URALCHEM's support is particularly important because the
treatment of Latvian residents outside the European Union is not
funded by the state. In practice, in cases with rare or complex
diseases, it is necessary to seek help outside Latvia. Children
deserve to have the highest level of treatment based on modern
scientific developments."
The
agreement stipulates that, within a specially designed charity
programme - "Help for seriously ill children", 20 children
from Latvia will be treated in leading medical institutions in Russia
during the coming year. The programme participants are selected by
the fund Ziedot.lv on the basis of doctor's recommendations and
requests from parents for financial assistance. Assistance is needed
in the treatment of diseases such as autism, vision recovery,
cerebral palsy and developmental delay.
With
this initiative by URALCHEM, Latvian children will now be able to
access world leading medical treatment not only within the EU but in
Russia as well.
-Ends-
Public
Relations Department
URALCHEM,
OJSC
Tel:
+7 (495) 721 89 89
E-Mail:
pr@URALCHEM.com
URALCHEM,
OJSC is one of the largest producers of nitrogen and phosphate
fertilisers in Russia and the CIS with production capacities of over
2.5 million tonnes of ammonium nitrate, 2.8 million tonnes of
ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of
complex fertilisers and 1.2 million tonnes of urea. URALCHEM, OJSC is
the second largest ammonium nitrate producer in the world and number
one in Russia, the second largest producer of nitrogen fertilisers in
Russia. Key production assets of URALCHEM, OJSC include Azot Branch
of URALCHEM, OJSC in Berezniki, Perm Region; OJSC Minudobrenia, Perm;
MFP Kirovo-Chepetsk Chemical Works, OJSC Branch in Kirovo-Chepetsk,
Kirov region; Voskresensk Mineral Fertilisers, OJSC in Voskresensk,
Moscow region.
Some
of the information in this press release may contain projections or
other forward-looking statements regarding future events or the
future financial performance of URALCHEM. We wish to caution you that
these statements are only predictions. We do not intend to update
these statements and our actual results may differ materially from
those contained in our projections or forward-looking statements,
including, among others, the achievement of anticipated levels of
profitability, growth, cost and synergy of our recent acquisitions,
the impact of competitive pricing, the ability to obtain necessary
regulatory approvals and licenses, the impact of developments in the
Russian economic, political and legal environment, financial risk
management and the impact of general business and global economic
conditions.
No comments:
Post a Comment